Structure-based drug discovery with deep learning
Artificial intelligence (AI) in the form of deep learning bears promise for drug discovery and chemical biology, $\textit{e.g.}$, to predict protein structure and molecular bioactivity, plan organic synthesis, and design molecules $\textit{de novo}$. While most of the deep learning efforts in drug discovery have focused on ligand-based approaches, structure-based drug discovery has the potential to tackle unsolved challenges, such as affinity prediction for unexplored protein targets, binding-mechanism elucidation, and the rationalization of related chemical kinetic properties. Advances in deep learning methodologies and the availability of accurate predictions for protein tertiary structure advocate for a $\textit{renaissance}$ in structure-based approaches for drug discovery guided by AI. This review summarizes the most prominent algorithmic concepts in structure-based deep learning for drug discovery, and forecasts opportunities, applications, and challenges ahead.
Code (0)
등록된 구현이 없습니다.
Tasks
Deep LearningDrug DiscoverySimilar Papers 제목 키워드 기반
A Survey of Graph Neural Networks for Drug Discovery: Recent Developments and Challenges
Graph Neural Networks (GNNs) have gained traction in the complex domain of drug discovery because of their ability to process graph-structured data such as drug molecule models. This approach has resulted in a myriad of …
Molecular Property PredictionDrug DiscoveryGraph-structured Small Molecule Drug Discovery Through Deep Learning: Progress, Challenges, and Opportunities
Due to their excellent drug-like and pharmacokinetic properties, small molecule drugs are widely used to treat various diseases, making them a critical component of drug discovery. In recent years, with the rapid develop…
Drug DiscoveryOut-of-Distribution GeneralizationCardiGraphormer: Unveiling the Power of Self-Supervised Learning in Revolutionizing Drug Discovery
In the expansive realm of drug discovery, with approximately 15,000 known drugs and only around 4,200 approved, the combinatorial nature of the chemical space presents a formidable challenge. While Artificial Intelligenc…
Drug DiscoverySelf-Supervised Learning3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery
Structure-based drug discovery, encompassing the tasks of protein-ligand docking and pocket-aware 3D drug design, represents a core challenge in drug discovery. However, no existing work can deal with both tasks to effec…
Drug DesignDrug DiscoveryNovel prediction methods for virtual drug screening
Drug development is an expensive and time-consuming process where thousands of chemical compounds are being tested in order to find those possessing drug-like properties while being safe and effective. One of key parts o…
Drug DiscoveryPrediction